"Managed Ventricular Pacing (MVP) Trial"

NATerminatedINTERVENTIONAL
Enrollment

1,031

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Heart Disease
Interventions
DEVICE

ICD (Implantable Cardioverter Defibrillator)

VVI 40 vs. MVP

Trial Locations (73)

Unknown

Anchorage

Little Rock

North Little Rock

Brandon

Clearwater

Fort Lauderdale

Naples

Pensacola

Atlanta

Savannah

Indianapolis

Des Moines

Kansas City

Lexington

Louisville

New Orleans

Baltimore

Silver Spring

Takoma Park

Detroit

Lansing

Marquette

Petoskey

Coon Rapids

Saint Paul

St Louis

Lebanon

Hackensack

Newark

New Hyde Park

New York

Gastonia

Raleigh

Mayfield Hts.

Oklahoma City

Tulsa

Allentown

Philadelphia

Columbia

Knoxville

Nashville

Austin

Fort Worth

Houston

Taylorville

Charlottesville

Norfolk

Richmond

Morgantown

Milwaukee

Sankt Pölten

Edmonton

Vancouver

Victoria

Ottawa

Montreal

Ste-Foy

Aarus

Le Chesnay

Lille

Bad Berka

Franfurt Am Main

Heidelberg

Homburg/Saar

Kiel

Haifa

Milano

Tel Aviv

Milan

Tromsø

Valencia

Zurich

London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY